World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
77
Citations
35166
World Ranking
18253
National Ranking
9107

Overview

Steven Z. Pavletic is affiliated with the National Institutes of Health in the United States. Their research activities predominantly lie within the broad field of Medicine, with a specific focus on Hematology, Immunology, Genetics, Public Health, Environmental and Occupational Health, and Surgery.

The scientist has contributed substantially to research on topics such as Hematopoietic Stem Cell Transplantation, Acute Lymphoblastic Leukemia, Mesenchymal Stem Cell research, Acute Myeloid Leukemia, T-cell and B-cell Immunology, Renal Transplantation Outcomes and Treatments, and Childhood Cancer Survivors' Quality of Life.

Their recent scholarly output includes several papers, notable among them:

  • Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study, 2021, Blood
  • National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report, 2021, Transplantation and Cellular Therapy
  • National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report, 2021, Transplantation and Cellular Therapy
  • Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide, 2020, Biology of Blood and Marrow Transplantation
  • Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force, 2022, Transplantation and Cellular Therapy

Frequent coauthors contributing to their research include:

  • Noa G. Holtzman
  • Stephanie J. Lee
  • Edward W. Cowen
  • Corey Cutler
  • Jacqueline W. Mays

Publications by Steven Z. Pavletic are commonly found in journals such as:

  • Transplantation and Cellular Therapy
  • Blood
  • Blood Advances
  • Bone Marrow Transplantation
  • British Journal of Haematology

Best Publications

  • National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report

    Madan H. Jagasia;Hildegard T. Greinix;Mukta Arora;Kirsten M. Williams

  • National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease

    Madan H. Jagasia;Hildegard T. Greinix;Mukta Arora;Kirsten M. Williams

  • ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells

    Daniel W. Lee;Bianca D. Santomasso;Frederick L. Locke;Armin Ghobadi

  • T Cells Genetically Modified to Express an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma

    Jennifer N. Brudno;Irina Maric;Steven D. Hartman;Jeremy J. Rose

  • Risk factors for acute GVHD and survival after hematopoietic cell transplantation.

    Madan Jagasia;Mukta Arora;Mary E D Flowers;Nelson J. Chao

  • Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group Report

    Stephanie J. Lee;Daniel Wolff;Carrie Kitko;John Koreth

  • Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease

    Jennifer N. Brudno;Robert P.T. Somerville;Victoria Shi;Jeremy J. Rose

  • Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation.

    James N. Kochenderfer;Mark E. Dudley;Robert O. Carpenter;Sadik H. Kassim

  • Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report.

    Howard M. Shulman;David Kleiner;Stephanie J. Lee;Thomas Morton

  • The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease.

    Kenneth R. Cooke;Leo Luznik;Stefanie Sarantopoulos;Frances T. Hakim

  • Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research

    Sally Arai;Mukta Arora;Tao Wang;Tao Wang;Stephen R. Spellman

  • Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium

    Joseph Pidala;Brenda Kurland;Xiaoyu Chai;Navneet S. Majhail

  • Randomized Phase III Trial of Fludarabine Plus Cyclophosphamide With or Without Oblimersen Sodium (Bcl-2 antisense) in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

    Susan O'Brien;Joseph O. Moore;Thomas E. Boyd;Loree M. Larratt

  • Ancillary Therapy and Supportive Care of Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. Ancillary Therapy and Supportive Care Working Group Report

    Daniel Couriel;Paul A. Carpenter;Corey Cutler;Javier Bolaños-Meade

  • Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease

    Stephanie J. Lee;Daniel Wolff;Carrie Kitko;John Koreth

  • EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment.

    Helene M. Schoemans;Stephanie J. Lee;James L. Ferrara;Daniel Wolff

  • Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease

    Daniel Wolff;Michael Schleuning;Stephanie von Harsdorf;Ulrike Bacher

  • High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis.

    Richard A. Nash;James D. Bowen;Peter A. McSweeney;Steven Z. Pavletic

  • Consensus Conference on Clinical Practice in Chronic Graft-versus-Host Disease (GVHD): First-Line and Topical Treatment of Chronic GVHD

    Daniel Wolff;Armin Gerbitz;Francis Ayuk;Alexander Kiani

  • NIH Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. The 2014 Pathology Working Group Report

    Howard M. Shulman;Diana M. Cardona;Joel K. Greenson;Sangeeta Hingorani;Sangeeta Hingorani;Sangeeta Hingorani

Frequent Co-Authors

Stephanie J. Lee
Stephanie J. Lee Fred Hutchinson Cancer Research Center
Ronald E. Gress
Ronald E. Gress National Institutes of Health
Seth M. Steinberg
Seth M. Steinberg National Institutes of Health
Corey Cutler
Corey Cutler Harvard University
Paul J. Martin
Paul J. Martin Fred Hutchinson Cancer Research Center
Daniel J. Weisdorf
Daniel J. Weisdorf University of Minnesota
Georgia Boyce Vogelsang
Georgia Boyce Vogelsang Johns Hopkins University
Mary M. Horowitz
Mary M. Horowitz Medical College of Wisconsin
David F. Stroncek
David F. Stroncek National Institutes of Health
Bipin N. Savani
Bipin N. Savani Vanderbilt University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA opens doors to many other health-related careers and online degrees. As healthcare evolves, more students are exploring online programs that offer flexibility and affordability without compromising quality.

For example, pharmd online programs allow aspiring pharmacists to earn a doctorate degree remotely, which is ideal for those looking to balance work and study. Similarly, health information technology programs online provide pathways into healthcare data management—a fast-growing field due to the digital transformation of patient records.

For students interested in the business side of healthcare, understanding medical billing and coding cost helps choose budget-friendly courses that lead to roles in healthcare administration. Additionally, those aiming to become advanced practice nurses can leverage the cheapest online fnp program options to prepare for family nurse practitioner roles.

These online degree pathways can lead to rewarding careers in healthcare without the traditional time and cost barriers of on-campus study.

Best Scientists Citing Steven Z. Pavletic

Trending Scientists

Recently Published Articles